SlideShare una empresa de Scribd logo
1 de 16
Descargar para leer sin conexión
Sterilizing Grade Filtration Validation & Qualification
The Difference between Being in Control & Fear




Maik W. Jornitz, Sartorius Stedim North America Inc.
Fundamentals: Being in Control & Fear

“Sandman’ s “control” principle might explain why most people are more
  scared of flying in an airplane than driving a car.
Their thinking goes like this: since I control the car, I am the one
  keeping myself safe; since I have no control of the airplane, I am at
  mercy of myriad external factors.” (Car death 11x higher/miles)
                                            Freakonomics, Levitt & Dubner (2005)




Same principle is at work, when sterilizing grade filtration is used,
discussed or promoted. The higher the lack of control the higher
the fear factor and utter reliance on so called “experts”.
What is “Being in Control”

Control =   archaic : to check, test, or verify by evidence or
             experiments   (Mirriam-Webster)



“Being in Control” is equivalent to Validation in Drug Processing


Validation is"Establishing documented evidence that provides a high
             degree of assurance that a specific process will
             consistently produce a product meeting its pre-
             determined specifications and quality attributes.“
             (FDA 1987)
“Being in Control” in Sterilizing Filtration
   Determine the appropriate filter for the application
   •   Flow rate
   •   Throughput
   •   Unspecific adsorption
   •   Compatibility
   •   etc.
   Perform process validation
   •   Viability test
   •   Bacteria challenge test with product under process conditions
   •   Extractable/leachable test
   •   etc.
   Integrity testing of the filter
   Routine control of up-stream bioburden (species/level)
Being in “Fear” in Sterilizing Filtration
   “0.2 µm filters are penetrated, the industry requires to switch
    to 0.1 µm rated filters”
   “increasingly, there are detectable, but non-culturable
    organisms or L-forms or nano-bacteria in our processes”
   “redundant 0.2 µm filtration is necessary and should be used”
   “I need an absolute 0.1 or 0.2 µm filter”
   “diffusive flow integrity testing is better than Bubble Point”
   “flawed filters will not be detected by a post-use test, as the
    flaw will be plugged during filtration”
   “the maximum bioburden in front of a sterile filter should be
    10 cfu/100 ml”
“Fear Factors”

Most are either driven by lack of knowledge or marketing !

                           Motivation: cover all bases       Motivation: sell more


    Most commonly:                                       Most commonly:
    •      Regulators                                    •     Experienced
    •      Consultants                                         vendor staff !
    •      Inexperienced
           vendor staff
                                                         Corrective action:
                                                             a critical educated
    Corrective action:                                       end-user
        Training
        Scientific discussions
        Open dialogue
Let’s get into Control
“0.2 µm filters are penetrated, the industry requires to switch to
 0.1 µm rated filters”

True ?


Yes, in some specific process, fluid and organism settings 0.2
µm are penetrated. This is not new, but has been addressed by
regulators and filter suppliers alike. (PDA/FDA Special Forum 1995)

This possibility has to be eliminated by Process Validation !

However, that does not mean the entire industry has to switch,
as experience shows that such instances are rare.(~0.005 – 0.01%)
Let’s get into Control, cont.
“redundant 0.2 µm filtration is necessary and should be used”

True ?


Not necessarily, again proper Process Validation will show
whether a single filter will do the job or not !

However, there are some specific applications, which utilize a
second (redundant) filter as “insurance” filter, i.e. the first filter
fails the second compensates. Though only when both filters
have been validated to show specified retentivity.

Be aware redundant filtration increases costs, extractables, hold-
up volume and unspecific adsorption. This requires evaluation.
Let’s get into Control, cont.
“diffusive flow integrity testing is better than Bubble Point”

True ?


No, both tests are valid, well exercised integrity tests !

In some applications, but especially in dimensional aspects the
individual integrity test has its benefits or need of use. For
example, Bubble Point testing should be used on small filter
areas.
Let’s get into Control, cont.
“the maximum bioburden in front of a sterile filter should be
 10 cfu/100 ml”

True ?

Yes, if one wants to export to Europe and fulfill the Note for
Guidance CPMP/QWP/486/95, which states such limit in front of
a sterilizing grade filter.

But does it make sense – No – as Process Validation commonly
challenges the filter at a higher level (107/cm2 or 1010/10” filter)
and determine the retentivity at process fluid and parameter
conditions.
Let’s get into Control, cont.
“I need an absolute 0.1 or 0.2 µm filter”
“Absolute should solely be used for vodka”   (Dr. Cooney, 2001)


“increasingly, there are detectable, but non-culturable
 organisms or L-forms or nano-bacteria in our processes”
Organisms adapt rapidly, however there is no scientific evidence
for an increase and especially nano-bacteria


“flawed filters will not be detected by a post-use test, as the
 flaw will be plugged during filtration”
So far we have not experienced this case, in thousands of
challenge tests and throughput studies
Are we in Control ?!

Yes, we are ! by the use of appropriate Process Validation !

Appropriate Process Validation determines:
    Fluid influences on the organisms
    Fluid influences on the membrane polymer
    Fluid influences on the retention mechanism
    Process parameter influences on the organisms
    Process parameter influences on the membrane polymer
    and filter construction
    Process parameter influences on the retention mechanism
Ultimately

We determine that the specified sterilizing grade filter works in
the process and fluid product specifications set.


“Works” means, the filter:
  retains the targeted organism and creates a sterile filtrate
  is thermal and mechanically stabile
  does not alter the product filtered (leachables, particulates,
  unspecific adsorption)
  performance as specified (flow rate, throughput)
  is readily available
Helpful Guidances
  PDA Technical Report #26, 2008

  FDA Aseptic Processing Guidance, 2004

  FDA Changes to NDA/ANDA, 2004

  EC GMP Guidance, Annex 1, 2008

  EMEA CPMP/QWP/486/95, 1996

  ISO 13408 Part 2, 2003

  PQRI PAC, 2007

  Warning Letters
Having said this...

Process validation is just one part of “Being in Control”.

The other, even more essential, as it could eliminate
everything done is the validation efforts, is...




                      TRAINING !
Thank you for your attention !

“Control your destiny or somebody else will.”
                                    Jack Welsh




maik.jornitz@sartorius-stedim.com

Más contenido relacionado

La actualidad más candente

Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...MilliporeSigma
 
Media fill process and validation
Media fill process and validationMedia fill process and validation
Media fill process and validationpaideeksha
 
IPQC Test for Liquid Dosage Forms
IPQC Test for Liquid Dosage FormsIPQC Test for Liquid Dosage Forms
IPQC Test for Liquid Dosage FormsMANIKANDAN V
 
ISS - Exposure Control Validation
ISS - Exposure Control ValidationISS - Exposure Control Validation
ISS - Exposure Control ValidationAbhinav Asthana
 
Akansha sterile product
Akansha sterile productAkansha sterile product
Akansha sterile productAkansha Sharma
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validationFasika Alemu
 
Media fill validation ppt (1)
Media fill validation ppt (1)Media fill validation ppt (1)
Media fill validation ppt (1)ShraddhaParmar15
 
HVAC & Water in Pharmaceutical Mnaufacturing; From Theory to Application
HVAC & Water in Pharmaceutical Mnaufacturing; From Theory to ApplicationHVAC & Water in Pharmaceutical Mnaufacturing; From Theory to Application
HVAC & Water in Pharmaceutical Mnaufacturing; From Theory to ApplicationObaid Ali / Roohi B. Obaid
 
One slider for qualification and validation of depyrogenation and sterilizati...
One slider for qualification and validation of depyrogenation and sterilizati...One slider for qualification and validation of depyrogenation and sterilizati...
One slider for qualification and validation of depyrogenation and sterilizati...Palash Das
 
Validation of sterilization
Validation of sterilizationValidation of sterilization
Validation of sterilizationKashf Rasheed
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validationdinesh pawar
 
Sterilization Standards Update: Strategies for Compliance
Sterilization Standards Update:  Strategies for ComplianceSterilization Standards Update:  Strategies for Compliance
Sterilization Standards Update: Strategies for ComplianceMedTech Review, LLC
 
Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...
Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...
Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...MilliporeSigma
 
ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterMerck Life Sciences
 
Fundamental of cleaning validation
Fundamental of cleaning validationFundamental of cleaning validation
Fundamental of cleaning validationEr. Vishal Katiyar
 
66 membrane filter integrity test
66 membrane filter integrity test66 membrane filter integrity test
66 membrane filter integrity testKethana Nellore
 
Cleaning validation presentation(1)
Cleaning validation presentation(1)Cleaning validation presentation(1)
Cleaning validation presentation(1)Randheer Dubey
 

La actualidad más candente (20)

Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...Reducing Contamination Risk and Improving Product Recovery During Final Steri...
Reducing Contamination Risk and Improving Product Recovery During Final Steri...
 
Media fill process and validation
Media fill process and validationMedia fill process and validation
Media fill process and validation
 
IPQC Test for Liquid Dosage Forms
IPQC Test for Liquid Dosage FormsIPQC Test for Liquid Dosage Forms
IPQC Test for Liquid Dosage Forms
 
ISS - Exposure Control Validation
ISS - Exposure Control ValidationISS - Exposure Control Validation
ISS - Exposure Control Validation
 
Akansha sterile product
Akansha sterile productAkansha sterile product
Akansha sterile product
 
Sterility assurance
Sterility assuranceSterility assurance
Sterility assurance
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Media fill validation ppt (1)
Media fill validation ppt (1)Media fill validation ppt (1)
Media fill validation ppt (1)
 
HVAC & Water in Pharmaceutical Mnaufacturing; From Theory to Application
HVAC & Water in Pharmaceutical Mnaufacturing; From Theory to ApplicationHVAC & Water in Pharmaceutical Mnaufacturing; From Theory to Application
HVAC & Water in Pharmaceutical Mnaufacturing; From Theory to Application
 
One slider for qualification and validation of depyrogenation and sterilizati...
One slider for qualification and validation of depyrogenation and sterilizati...One slider for qualification and validation of depyrogenation and sterilizati...
One slider for qualification and validation of depyrogenation and sterilizati...
 
Validation of sterilization
Validation of sterilizationValidation of sterilization
Validation of sterilization
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Sterilization Standards Update: Strategies for Compliance
Sterilization Standards Update:  Strategies for ComplianceSterilization Standards Update:  Strategies for Compliance
Sterilization Standards Update: Strategies for Compliance
 
Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...
Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...
Webinar: How a Helium Manufacturing Release Test Increases Integrity Assuranc...
 
ADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and fasterADC Production - A Journey made safer and faster
ADC Production - A Journey made safer and faster
 
Fundamental of cleaning validation
Fundamental of cleaning validationFundamental of cleaning validation
Fundamental of cleaning validation
 
66 membrane filter integrity test
66 membrane filter integrity test66 membrane filter integrity test
66 membrane filter integrity test
 
Cleaning validation presentation(1)
Cleaning validation presentation(1)Cleaning validation presentation(1)
Cleaning validation presentation(1)
 
Lifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning ValidationLifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning Validation
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 

Destacado (10)

Filter Validation and Regulatory aspects
Filter Validation and Regulatory aspectsFilter Validation and Regulatory aspects
Filter Validation and Regulatory aspects
 
Validation of membrane filter
Validation of membrane filterValidation of membrane filter
Validation of membrane filter
 
Particle Technology- Filtration
Particle Technology- FiltrationParticle Technology- Filtration
Particle Technology- Filtration
 
Membrane separation processe
Membrane separation processeMembrane separation processe
Membrane separation processe
 
Q922+rfp+l09 v1
Q922+rfp+l09 v1Q922+rfp+l09 v1
Q922+rfp+l09 v1
 
Membrane technology
Membrane technologyMembrane technology
Membrane technology
 
Filtration
FiltrationFiltration
Filtration
 
Filtration and Clarification
Filtration and ClarificationFiltration and Clarification
Filtration and Clarification
 
Filtration
FiltrationFiltration
Filtration
 
Filtration
FiltrationFiltration
Filtration
 

Similar a Interphex April 2010

Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingMerck Life Sciences
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingMilliporeSigma
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceMilliporeSigma
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceMerck Life Sciences
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationMerck Life Sciences
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationMilliporeSigma
 
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testingVisual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testingKarishmaRK
 
Redacted bpsa particulate paper bpog 150115 (1)
Redacted bpsa particulate paper bpog 150115 (1)Redacted bpsa particulate paper bpog 150115 (1)
Redacted bpsa particulate paper bpog 150115 (1)BioPhorum Operations Group
 
Investigating variation
Investigating variationInvestigating variation
Investigating variationTerungwa Ujoh
 
Potential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing FiltrationPotential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing FiltrationMilliporeSigma
 
membrane filtration
membrane filtrationmembrane filtration
membrane filtrationAnkit Sharma
 
Biotech -validation.ppt
Biotech -validation.pptBiotech -validation.ppt
Biotech -validation.pptssusera7f12d
 
PDA Virtual Training Optimizing Processes 03 2006
PDA Virtual Training Optimizing Processes 03 2006PDA Virtual Training Optimizing Processes 03 2006
PDA Virtual Training Optimizing Processes 03 2006MWJornitz
 
Sterile process validation
Sterile process validationSterile process validation
Sterile process validationSagar Savale
 
Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...
Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...
Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...Kailash Vilegave
 
White paper - Key factors for developing a pharmaceutical cleaning strategy
White paper - Key factors for developing a pharmaceutical cleaning strategyWhite paper - Key factors for developing a pharmaceutical cleaning strategy
White paper - Key factors for developing a pharmaceutical cleaning strategyFedegari Group
 
Manufacturing Science - August 5 2004 FDA Pharmaceutical Inspectorate Training
Manufacturing Science -  August 5 2004  FDA Pharmaceutical Inspectorate TrainingManufacturing Science -  August 5 2004  FDA Pharmaceutical Inspectorate Training
Manufacturing Science - August 5 2004 FDA Pharmaceutical Inspectorate TrainingAjaz Hussain
 

Similar a Interphex April 2010 (20)

Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
 
Single-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed ProcessingSingle-Use Tangential Flow Filtration for Closed Processing
Single-Use Tangential Flow Filtration for Closed Processing
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
 
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter ValidationEU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
EU GMP Annex 1 Draft: Implications on Sterilizing Grade Filter Validation
 
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testingVisual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
Visual Inspection of Parentetal Drug Products in Pharmaceutical Quality testing
 
Redacted bpsa particulate paper bpog 150115 (1)
Redacted bpsa particulate paper bpog 150115 (1)Redacted bpsa particulate paper bpog 150115 (1)
Redacted bpsa particulate paper bpog 150115 (1)
 
Lv1 bio beers pdf
Lv1 bio beers pdfLv1 bio beers pdf
Lv1 bio beers pdf
 
Investigating variation
Investigating variationInvestigating variation
Investigating variation
 
Potential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing FiltrationPotential Impact of Draft Annex 1 on Sterilizing Filtration
Potential Impact of Draft Annex 1 on Sterilizing Filtration
 
membrane filtration
membrane filtrationmembrane filtration
membrane filtration
 
Biotech -validation.ppt
Biotech -validation.pptBiotech -validation.ppt
Biotech -validation.ppt
 
PDA Virtual Training Optimizing Processes 03 2006
PDA Virtual Training Optimizing Processes 03 2006PDA Virtual Training Optimizing Processes 03 2006
PDA Virtual Training Optimizing Processes 03 2006
 
Sterile process validation
Sterile process validationSterile process validation
Sterile process validation
 
Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...
Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...
Validation by Vilegave Kailash, Shivajirao S. Jondhle college of Pharmacy Asa...
 
White paper - Key factors for developing a pharmaceutical cleaning strategy
White paper - Key factors for developing a pharmaceutical cleaning strategyWhite paper - Key factors for developing a pharmaceutical cleaning strategy
White paper - Key factors for developing a pharmaceutical cleaning strategy
 
Qa and qc seminar
Qa and qc seminarQa and qc seminar
Qa and qc seminar
 
4 - Tutorial
4 - Tutorial4 - Tutorial
4 - Tutorial
 
Manufacturing Science - August 5 2004 FDA Pharmaceutical Inspectorate Training
Manufacturing Science -  August 5 2004  FDA Pharmaceutical Inspectorate TrainingManufacturing Science -  August 5 2004  FDA Pharmaceutical Inspectorate Training
Manufacturing Science - August 5 2004 FDA Pharmaceutical Inspectorate Training
 

Más de MWJornitz

G con future flexible facility - mj 03-2015
G con future flexible facility  - mj 03-2015G con future flexible facility  - mj 03-2015
G con future flexible facility - mj 03-2015MWJornitz
 
Future flexible facility needs - mj 06-2016
Future flexible facility needs - mj 06-2016Future flexible facility needs - mj 06-2016
Future flexible facility needs - mj 06-2016MWJornitz
 
Flexible Facilities for ATMPs
Flexible Facilities for ATMPsFlexible Facilities for ATMPs
Flexible Facilities for ATMPsMWJornitz
 
Pda fda joint conference - 09-2008
Pda fda joint conference - 09-2008Pda fda joint conference - 09-2008
Pda fda joint conference - 09-2008MWJornitz
 
PDA Annual Meeting 2010 - Single-use technology up-date
PDA Annual Meeting 2010 - Single-use technology up-datePDA Annual Meeting 2010 - Single-use technology up-date
PDA Annual Meeting 2010 - Single-use technology up-dateMWJornitz
 
Position Paper Pre Use It Mwj 01 11 1
Position Paper  Pre Use It Mwj 01 11 1Position Paper  Pre Use It Mwj 01 11 1
Position Paper Pre Use It Mwj 01 11 1MWJornitz
 
PDA Annual Meeting Orlando March 2010 Mj
PDA Annual Meeting Orlando March 2010 MjPDA Annual Meeting Orlando March 2010 Mj
PDA Annual Meeting Orlando March 2010 MjMWJornitz
 
PDA FDA Joint Conference 09 2008
PDA FDA Joint Conference   09 2008PDA FDA Joint Conference   09 2008
PDA FDA Joint Conference 09 2008MWJornitz
 

Más de MWJornitz (8)

G con future flexible facility - mj 03-2015
G con future flexible facility  - mj 03-2015G con future flexible facility  - mj 03-2015
G con future flexible facility - mj 03-2015
 
Future flexible facility needs - mj 06-2016
Future flexible facility needs - mj 06-2016Future flexible facility needs - mj 06-2016
Future flexible facility needs - mj 06-2016
 
Flexible Facilities for ATMPs
Flexible Facilities for ATMPsFlexible Facilities for ATMPs
Flexible Facilities for ATMPs
 
Pda fda joint conference - 09-2008
Pda fda joint conference - 09-2008Pda fda joint conference - 09-2008
Pda fda joint conference - 09-2008
 
PDA Annual Meeting 2010 - Single-use technology up-date
PDA Annual Meeting 2010 - Single-use technology up-datePDA Annual Meeting 2010 - Single-use technology up-date
PDA Annual Meeting 2010 - Single-use technology up-date
 
Position Paper Pre Use It Mwj 01 11 1
Position Paper  Pre Use It Mwj 01 11 1Position Paper  Pre Use It Mwj 01 11 1
Position Paper Pre Use It Mwj 01 11 1
 
PDA Annual Meeting Orlando March 2010 Mj
PDA Annual Meeting Orlando March 2010 MjPDA Annual Meeting Orlando March 2010 Mj
PDA Annual Meeting Orlando March 2010 Mj
 
PDA FDA Joint Conference 09 2008
PDA FDA Joint Conference   09 2008PDA FDA Joint Conference   09 2008
PDA FDA Joint Conference 09 2008
 

Interphex April 2010

  • 1. Sterilizing Grade Filtration Validation & Qualification The Difference between Being in Control & Fear Maik W. Jornitz, Sartorius Stedim North America Inc.
  • 2. Fundamentals: Being in Control & Fear “Sandman’ s “control” principle might explain why most people are more scared of flying in an airplane than driving a car. Their thinking goes like this: since I control the car, I am the one keeping myself safe; since I have no control of the airplane, I am at mercy of myriad external factors.” (Car death 11x higher/miles) Freakonomics, Levitt & Dubner (2005) Same principle is at work, when sterilizing grade filtration is used, discussed or promoted. The higher the lack of control the higher the fear factor and utter reliance on so called “experts”.
  • 3. What is “Being in Control” Control = archaic : to check, test, or verify by evidence or experiments (Mirriam-Webster) “Being in Control” is equivalent to Validation in Drug Processing Validation is"Establishing documented evidence that provides a high degree of assurance that a specific process will consistently produce a product meeting its pre- determined specifications and quality attributes.“ (FDA 1987)
  • 4. “Being in Control” in Sterilizing Filtration Determine the appropriate filter for the application • Flow rate • Throughput • Unspecific adsorption • Compatibility • etc. Perform process validation • Viability test • Bacteria challenge test with product under process conditions • Extractable/leachable test • etc. Integrity testing of the filter Routine control of up-stream bioburden (species/level)
  • 5. Being in “Fear” in Sterilizing Filtration “0.2 µm filters are penetrated, the industry requires to switch to 0.1 µm rated filters” “increasingly, there are detectable, but non-culturable organisms or L-forms or nano-bacteria in our processes” “redundant 0.2 µm filtration is necessary and should be used” “I need an absolute 0.1 or 0.2 µm filter” “diffusive flow integrity testing is better than Bubble Point” “flawed filters will not be detected by a post-use test, as the flaw will be plugged during filtration” “the maximum bioburden in front of a sterile filter should be 10 cfu/100 ml”
  • 6. “Fear Factors” Most are either driven by lack of knowledge or marketing ! Motivation: cover all bases Motivation: sell more Most commonly: Most commonly: • Regulators • Experienced • Consultants vendor staff ! • Inexperienced vendor staff Corrective action: a critical educated Corrective action: end-user Training Scientific discussions Open dialogue
  • 7. Let’s get into Control “0.2 µm filters are penetrated, the industry requires to switch to 0.1 µm rated filters” True ? Yes, in some specific process, fluid and organism settings 0.2 µm are penetrated. This is not new, but has been addressed by regulators and filter suppliers alike. (PDA/FDA Special Forum 1995) This possibility has to be eliminated by Process Validation ! However, that does not mean the entire industry has to switch, as experience shows that such instances are rare.(~0.005 – 0.01%)
  • 8. Let’s get into Control, cont. “redundant 0.2 µm filtration is necessary and should be used” True ? Not necessarily, again proper Process Validation will show whether a single filter will do the job or not ! However, there are some specific applications, which utilize a second (redundant) filter as “insurance” filter, i.e. the first filter fails the second compensates. Though only when both filters have been validated to show specified retentivity. Be aware redundant filtration increases costs, extractables, hold- up volume and unspecific adsorption. This requires evaluation.
  • 9. Let’s get into Control, cont. “diffusive flow integrity testing is better than Bubble Point” True ? No, both tests are valid, well exercised integrity tests ! In some applications, but especially in dimensional aspects the individual integrity test has its benefits or need of use. For example, Bubble Point testing should be used on small filter areas.
  • 10. Let’s get into Control, cont. “the maximum bioburden in front of a sterile filter should be 10 cfu/100 ml” True ? Yes, if one wants to export to Europe and fulfill the Note for Guidance CPMP/QWP/486/95, which states such limit in front of a sterilizing grade filter. But does it make sense – No – as Process Validation commonly challenges the filter at a higher level (107/cm2 or 1010/10” filter) and determine the retentivity at process fluid and parameter conditions.
  • 11. Let’s get into Control, cont. “I need an absolute 0.1 or 0.2 µm filter” “Absolute should solely be used for vodka” (Dr. Cooney, 2001) “increasingly, there are detectable, but non-culturable organisms or L-forms or nano-bacteria in our processes” Organisms adapt rapidly, however there is no scientific evidence for an increase and especially nano-bacteria “flawed filters will not be detected by a post-use test, as the flaw will be plugged during filtration” So far we have not experienced this case, in thousands of challenge tests and throughput studies
  • 12. Are we in Control ?! Yes, we are ! by the use of appropriate Process Validation ! Appropriate Process Validation determines: Fluid influences on the organisms Fluid influences on the membrane polymer Fluid influences on the retention mechanism Process parameter influences on the organisms Process parameter influences on the membrane polymer and filter construction Process parameter influences on the retention mechanism
  • 13. Ultimately We determine that the specified sterilizing grade filter works in the process and fluid product specifications set. “Works” means, the filter: retains the targeted organism and creates a sterile filtrate is thermal and mechanically stabile does not alter the product filtered (leachables, particulates, unspecific adsorption) performance as specified (flow rate, throughput) is readily available
  • 14. Helpful Guidances PDA Technical Report #26, 2008 FDA Aseptic Processing Guidance, 2004 FDA Changes to NDA/ANDA, 2004 EC GMP Guidance, Annex 1, 2008 EMEA CPMP/QWP/486/95, 1996 ISO 13408 Part 2, 2003 PQRI PAC, 2007 Warning Letters
  • 15. Having said this... Process validation is just one part of “Being in Control”. The other, even more essential, as it could eliminate everything done is the validation efforts, is... TRAINING !
  • 16. Thank you for your attention ! “Control your destiny or somebody else will.” Jack Welsh maik.jornitz@sartorius-stedim.com